CAV1 and neoplasm: Mechanistically, the edited COPA (COPA^I164V) attenuates tumor growth by suppressing the PI3K/AKT/mTOR pathway via downregulation of Caveolin-1 (CAV1), thereby decreasing mTOR-driven cell proliferation and survival (88).